RANCHO CORDOVA, Calif., Oct. 19 /PRNewswire-FirstCall/ -- ThermoGenesis (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today that Jorge F. Artiles has joined the Company as Vice President, Chief Quality and Regulatory Affairs Officer, effective immediately.
Artiles has more than two decades of quality and regulatory affairs experience in the medical device industry, with expertise in quality system development and compliance, project management and process optimization.
Most recently, Artiles was Vice President, Quality Assurance and Regulatory Affairs, for Physio Control, a division of Medtronic. Before that, he held a similar position at Cytyc Surgical Products, where he was responsible for quality and regulatory affairs at two manufacturing sites. Artiles has also held quality and regulatory management positions with Teleflex Medical, Abbott Laboratories, Boston Scientific and Baxter Healthcare. He holds a B.S. in Industrial Technology and an M.S. in Quality Assurance and Industrial Technology from San Jose State University.
"While we have made significant progress with our product quality initiatives over the past year, Jorge brings a level of expertise and experience that will be critical to our growth as we expand our product offerings and develop new market opportunities," said J. Melville Engle, Chief Executive Officer of ThermoGenesis.
"He has extensive experience in developing and managing quality assurance programs and procedures, implementing sourcing, manufacturing and cost control initiatives and ensuring regulatory compliance within both large organizations and at a divisional level," Engle added.
About ThermoGenesis Corp.
ThermoGenesis Corp. (www.thermogenesi
|SOURCE ThermoGenesis Corp.|
Copyright©2009 PR Newswire.
All rights reserved